Risk of Serious Bacterial Infection in Infants Aged ≤60 Days Presenting to Emergency Departments with a History of Fever Only

Meningitis

Accuracy of Complete Blood Cell Counts to Identify Febrile Infants 60 Days or Younger With Invasive Bacterial Infections

JAMA Pediatr.

Cruz AT, Mahajan P, Bonsu BK, Bennett JE, Levine DA, Alpern ER, Nigrovic LE, Atabaki SM, Cohen DM, VanBuren JM, Ramilo O, Kuppermann N; Febrile Infant Working Group of the Pediatric Emergency Care Applied Research Network

doi: 10.1001/

Bacterial InfectionsMeningitisViral Infections, Non-HIV

Rhinovirus in Febrile Infants and Risk of Bacterial Infection

Pediatrics.

Blaschke AJ, Korgenski EK, Wilkes J, Presson AP, Thorell EA, Pavia AT, Knackstedt ED, Reynolds C, Schunk JE, Daly JA, Byington CL

doi: 10.1542/peds.2017-2384.

Bacterial Infections

Accuracy of Current Diagnostic Criteria for Acute Bacterial Infection in Older Adults in the Emergency Department

J Am Geriatr Soc.

Caterino JM, Leininger R, Kline DM, Southerland LT, Khaliqdina S, Baugh CW, Pallin DJ, Stevenson KB

doi: 10.1111/jgs.14912.

Bacterial Infections

Factors Associated with Adverse Outcomes among Febrile Young Infants with Invasive Bacterial Infections

J Pediatr.

Pruitt CM, Neuman MI, Shah SS, Shabanova V, Woll C, Wang ME, Alpern ER, Williams DJ, Sartori L, Desai S, Leazer RC, Marble RD, McCulloh RJ, DePorre AG, Rooholamini SN, Lumb CE, Balamuth F, Shin S, Aronson PL; Febrile Young Infant Research Collaborative

doi: 10.1016/j.jpeds.2018.08.066.

Bacterial Infections

Trends in Intravenous Antibiotic Duration for Urinary Tract Infections in Young Infants

Pediatrics.

Lewis-de Los Angeles WW, Thurm C, Hersh AL, Shah SS, Smith MJ, Gerber JS, Parker SK, Newland JG, Kronman MP, Lee BR, Brogan TV, Courter JD, Spaulding A, Patel SJ

doi: 10.1542/peds.2017-1021.

Bacterial Infections

Antibiotic prescribing choices and their comparative C. difficile infection risks: a longitudinal case-cohort study

Clin Infect Dis.

Brown KA, Langford B, Schwartz KL, Diong C, Garber G, Daneman N

doi: 10.1093/cid/ciaa124.

Bacterial Infections

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

Clin Microbiol Infect.

Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JR, Daneman N

doi: 10.1016/j.cmi.2020.07.016.

Viral Infections, Non-HIV

Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study

Lancet Infect Dis

Li F, Li YY, Liu MJ, Fang LQ, Dean NE, Wong GWK, Yang XB, Longini I, Halloran ME, Wang HJ, Liu PL, Pang YH, Yan YQ, Liu S, Xia W, Lu XX, Liu Q, Yang Y, Xu SQ

doi: 10.1016/S1473-3099(20)30981-6

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

Lancet Infect Dis.

Guery B, Menichetti F, Anttila VJ, Adomakoh N, Aguado JM, Bisnauthsing K, Georgopali A, Goldenberg SD, Karas A, Kazeem G, Longshaw C, Palacios-Fabrega JA, Cornely OA, Vehreschild MJGT; EXTEND Clinical Study Group

doi: 10.1016/

Related content

Accuracy of Complete Blood Cell Counts to Identify Febrile Infants 60 Days or Younger With Invasive Bacterial Infections

Rhinovirus in Febrile Infants and Risk of Bacterial Infection

Accuracy of Current Diagnostic Criteria for Acute Bacterial Infection in Older Adults in the Emergency Department

Factors Associated with Adverse Outcomes among Febrile Young Infants with Invasive Bacterial Infections

Trends in Intravenous Antibiotic Duration for Urinary Tract Infections in Young Infants

Antibiotic prescribing choices and their comparative C. difficile infection risks: a longitudinal case-cohort study

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial